Beth A. Schrope, MD, PhD

Surgery, General (Board Certified, Primary Specialty)
Cancer Care
Office Phone: (212) 305-9441

Biography

Dr. Schrope joined the faculty of the Department of Surgery in July of 2001 as a Clinical instructor after completing her residency with NewYork-Presbyterian Hospital. She is currently Associate Professor of Clinical Surgery.

She graduated with an M.D. degree from Temple University in 1996. Prior to joining the profession of medicine, she completed a Ph. D. in Biomedical Engineering at Drexel University in 1992, and won numerous federal grants as principle investigator for research work in medical ultrasound. She is the author of numerous publications in the fields of bariatric surgery, medical ultrasound and GI surgery. She is the sole editor of a new textbook on Surgical and Interventional Ultrasound.

Her research interests include novel applications of autologous pancreatic islet cell transplantation, pancreatic cysts and pancreatitis. She also employs minimally invasive surgical techniques for benign and malignant conditions of the stomach. Dr. Schrope is an active member of the American College of Surgeons, the American HepatoPancreaticoBiliary Association, and Society of Surgery of the Alimentary Tract. She is currently serving as Regional Medical Director of the Southern New York chapter of the National Pancreas Foundation.

Area of Expertise

Please contact the doctor's office to verify that your insurance is accepted.

Aetna [EPO, HMO, Medicare Managed Care, NY Signature, POS, PPO, Signature Administrators, Student Health]

Affinity [Access (Exchange), Essential Plan, Medicaid Managed Care, Medicare Managed Care]

Cigna [EPO, Great West, HMO, POS, PPO]

Emblem/HIP [ConnectiCare, EPO, Essential Plan, HMO, Medicaid Managed Care, Medicare Managed Care, POS, PPO, Select Care (Exchange), Vytra]

Empire Blue Cross Blue Shield [Blue Priority, EPO, HMO, Medicare (Mediblue), NYP Employee Plan, Pathway (Exchange), POS, PPO]

Empire Blue Cross Blue Shield HealthPlus [Child/Family Health Plus, Essential Plan, Medicaid Managed Care]

Fidelis Care [Child/Family Health Plus, Medicaid Managed Care, Medicare Managed Care]

GHI [HMO, PPO]

Healthfirst [Child/Family Health Plus, Medicaid Managed Care, Medicare Managed Care]

Horizon Blue Cross Blue Shield [PPO]

Local 1199

MagnaCare

Medicare [Railroad]

Multiplan

Oxford Health Plans [Freedom, Liberty, Medicare Managed Care]

POMCO

UnitedHealthcare [Columbia University Employee Plan, Compass (Exchange), EPO, HMO, Medicaid (Community Plan), Medicare Managed Care, POS, PPO, The Empire Plan (NYSHIP)]

Education

Temple University School of Medicine

Internship: NewYork-Presbyterian Hospital/Columbia University Medical Center

Residency: NewYork-Presbyterian Hospital/Columbia University Medical Center

Publications

  • Ozcan L, Ghorpade D, Zheng Z, de Souza J, Chen K, Bessler M, Bagloo M, Schrope B, Pestell R, Tabas I “Hepatocyte DACH1 Is Increased in Obesity via Nuclear Exclusion of HDAC4 and Promotes Hepatic Insulin Resistance,” Cell Reports 15, 2214–2225, June 7, 2016.
  • Rutkoski, J, Schrope, B, Lee, B, “Survival Following Gastro-Left Ventricular Fistula in a Patient Post Roux-en-Y Gastric Bypass,” The Annals of Thoracic Surgery, accepted for publication.
  • Ge, F, Walewski, JL, Torghabeh, MH, Lobdell, H, Hu, C, Zhou, S, Dakin, G, Pomp, A, Bessler, M, Schrope, B, Ude-Welcome, A, Inabnet, W, Feng, T, Carras-Terzian, E, Anglade, D, Ebel, F, Berk, PD, “Facilitated long chain fatty acid uptake by adipocytes remains upregulated relative to BMI for more than a year after major bariatric surgical weight loss,” Obesity, 2016 Jan; 24(1):113-22.
  • Kluger MD, Epelboym I, Schrope BA, Mahendraraj K, Hecht EM, Susman J, Weintraub JL, Chabot JA.., “Single-Institution Experience with Irreversible Electroporation for T4 Pancreatic Cancer: First 50 Patients,” Ann Surg Oncol., 23(5), 1736-1743.
  • Dorfman, V, Sethi, A, Poneros, J, Allendorf, J, Gress, F, Schrope, B, Chabot, J, Gonda, T, “Progression of Incidental Intraductal Papillary Mucinous Neoplasms of the Pancreas in Liver Transplant Recipients,” Pancreas, 2015 Oct 22. [Epub ahead of print].
  • Sherman, WH; Chu, K; Chabot, J; Allendorf, J; Schrope, B; Hecht, E; Jin, B; Leung, D; Remotti, H; Addeo, G; Postolov, I; Tsai, W; and Fine, RL, “Neoadjuvant Gemcitabine, Docetaxel, and Capecitabine Followed by Gemcitabine and Capecitabine/Radiation Therapy and Surgery in Locally Advanced, Unresectable Pancreatic Adenocarcinoma,” Cancer. 2015 Mar 1;121(5):673-80.
  • Rosenblatt R, Dorfman V, Epelboym I, Poneros JM, Sethi A, Lightdale C, Woo Y, Gress FG, Allendorf JD, Schrope BA, Chabot JA, Gonda TA, “Demographic Features and Natural History of Intermediate-Risk Multifocal Versus Unifocal Intraductal Papillary Mucinous Neoplasms,” Pancreas. 2015 Apr;44(3):478-83.
  • Mitchell JE, King WC, Chen JY, Devlin MJ, Flum D, Garcia L, Pender JR, Kalarchian MA, Khandelwal S, Marcus MD, Schrope B, Strain G, Wolfe B, Yanovski S., “Course of depressive symptoms and treatment in the longitudinal assessment of bariatric surgery (LABS-2) study,” Obesity, 2014 Aug;22(8):1799-806.
  • Epelboym I, Gawlas I, Lee JA, Schrope B, Chabot JA, Allendorf JD, ”Limitations of ACS-NSQIP in Reporting Complications for Patients Undergoing Pancreatectomy: Underscoring the Need for a Pancreas-Specific Module. World J Surg. 2014 May;38(5):1184-95.
  • Purnell JQ, Selzer F, Smith MD, Berk PD, Courcoulas AP, Inabnet WB, King WC, Pender J, Pomp A, Raum WJ, Schrope B, Steffen KJ, Wolfe BM, Patterson EJ, “Metabolic syndrome prevalence and associations in a bariatric surgery cohort from the longitudinal assessment of bariatric surgery-2 study,”.Metab Syndr Relat Disord. 2014 Mar;12(2):86-94.
  • Gawlas I, Epelboym I, Winner M, DiNorcia J, Woo Y, Lee JL, Schrope BA, Chabot JA, Allendorf JD, ”Short-term but not long-term loss of patency of venous reconstruction during pancreatic resection is associated with decreased survival.”J Gastrointest Surg. 2014 Jan;18(1):75-82.
  • Epelboym I, Dinorcia J, Winner M, Lee MK, Lee JA, Schrope BA, Chabot JA, Allendorf JD, “Neoadjuvant Therapy and Vascular Resection During Pancreaticoduodenectomy: Shifting the Survival Curve for Patients with Locally Advanced Pancreatic Cancer,”. World J Surg. 2014 May;38(5):1184-95.
  • Irene Epelboym, Megan Winner, Joseph DiNorcia, Minna K. Lee, James A. Lee, Beth Schrope, John A. Chabot, John D. Allendorf, “Quality of life in patients after total pancreatectomy is comparable with quality of life in patients who undergo a partial pancreatic resection,” Journal of Surgical Research, 2014 Mar;187(1):189-96.
  • Belle SH, Berk PD, Courcoulas AP, Engel S, Flum DR, Gourash W, Horlick M, Hsu JY, Khandelwal S, Mitchell JE, O'Rourke RW, Pories W, Schrope B, Wolfe B; for The LABS Consortium Weight Change Writing Group. “Reporting weight change: standardized reporting accounting for baseline weight.” Surg Obes Relat Dis. 2013 Sep-Oct; 9(5):782-9.
  • Winner M, Epelboym I, Remotti H, Lee JL, Schrope BA, Chabot JA, Allendorf JD., “Predictors of recurrence in intraductal papillary mucinous neoplasm: experience with 183 pancreatic resections., J Gastrointest Surg. 2013 Sep;17(9):1618-26.
  • Fine, R., Gulati, A., Krantz, B., Moss, R., Schreibman, S., Tsushima, D.,  Mowatt, K., Dinnen, R., Mao, Y., Stevens, P., Schrope, B., Allendorf, J., Lee, J., Sherman, W., and Chabot, J. “Capecitabine and Temozolomide (CAPTEM) for Metastatic, Well-Differentiated Neuroendocrine Cancers: The Pancreas Center at Columbia University Experience.” Cancer Chemother Pharmacol. 2013 Mar;71(3):663-70.
  • Stein EM, Carrelli A, Young P, Bucovsky M, Zhang C, Schrope B, Bessler M, Zhou B, Wang J, Guo XE, McMahon DJ, Silverberg SJ., ” Bariatric Surgery Results in Cortical Bone Loss,” J Clin Endocrinol Metab.  2013 Feb;98(2):541-9.
  • Gawlas I, Sethi M, Winner M, Epelboym I, Lee JL, Schrope BA, Chabot JA, Allendorf JD. “Readmission After Pancreatic Resection is not an Appropriate Measure of Quality.” Ann Surg Oncol. 2013 Jun;20(6):1781-7.
  • Smith MD, Patterson E, Wahed AS, Belle SH, Berk PD, Courcoulas AP, Dakin GF, Flum DR, Machado L, Mitchell JE, Pender J, Pomp A, Pories W, Ramanathan R, Schrope B, Staten M, Ude A, Wolfe BM. “Thirty-day mortality after bariatric surgery: independently adjudicated causes of death in the longitudinal assessment of bariatric surgery.”Obes Surg. 2011 Nov;21(11):1687-92.
  • Im, G., Stavropoulos, S., Schrope, B., “An Unusual Cause of Pancreatitis,”Gastroenterology, Volume 141, Issue 6, December 2011, pp e9-e10.
  • Lee, M., DiNorcia, J,.  Reavey, P., Holden, B., Genkinger, J., Lee, J., Schrope, B., Chabot, J., Allendorf, J., “Pancreaticoduodenectomy can be safely performed in patients aged 80 years and older,” Journal of Gastrointestinal Surgery, 2010, 14(11), pp. 1838-46.
  • DiNorcia, J,.  Schrope, B., Lee, M., Reavey, P., Rosen, S., Lee, J., Chabot, J., Allendorf, J., “Laparoscopic distal pancreatectomy offers shorter hospital stays with fewer complications,” Journal of Gastrointestinal Surgery, 2010, 14(11), pp. 1804-12.
  • DiNorcia, J,.  Ahmed, L., Lee, M., Reavey, P., Yakaitis, E,. Lee, J., Schrope, B., Chabot, J., Allendorf, J., “Better preservation of endocrine function after central versus distal pancreatectomy for mid-gland lesions,” Surgery, Volume 148, Issue 6, December 2010, pp 1247-1256.
  • Botwinick IC, Schrope BA, Chabot JA. “Distal pancreatectomy with en bloc celiac axis resection after neoadjuvant therapy for locally advanced pancreatic adenocarcinoma.” Pancreas. 2010 Oct;39(7):1111-3.
  • DiNorcia J, Lee MK, Reavey PL, Genkinger JM, Lee JA, Schrope BA, Chabot JA, Allendorf JD. One hundred thirty resections for pancreatic neuroendocrine tumor: evaluating the impact of minimally invasive and parenchyma-sparing techniques.” J Gastrointest Surg. 2010 Oct;14(10):1536-46.
  • Gosman, G., King, W., Schrope, B., Steffen, K., Strain, G., Courcoulas, A., Flum, D., Pender, J., Simhan, H., “Reproductive health of women electing bariatric surgery,” Fertility and Sterility, Volume 94, Issue 4, September 2010, pp 1426-1431.
  • Gosman, G., Simhan, H., Courcoulas, A., King, W., Schrope, B., Steffen, K., Strain, G., Flum, D., Pender, J., “Reply of the Authors: Polycystic ovary syndrome is common in patients undergoing bariatric surgery in a British center,” Fertility and Sterility, Volume 94, Issue 2, July 2010, p e42.
  • Bessler, M., Daud, A., DiGiorgi, M., Inabnet, W., Schrope, B., Olivero-Rivera, L., Davis, D., “Adjustable gastric banding as revisional bariatric procedure after failed gastric bypass – intermediate results,” Surgery for Obesity and Related Diseases, Volume 6, Number 1, January/February 2010, pp 31-5.
  • Choi, J., Digiorgi, M., Milone, L., Schrope, B., Olivera-Rivera, L., Daud, A., Davis, D., Bessler, M., “Outcomes of laparoscopic adjustable gastric banding in patients with low body mass index,” Surgery for Obesity and Related Diseases, Volume 6, Number 4, July/August 2010, pp 367-72.
  • DiGiorgi, M., Rosen, D., Choi, J., Milone, L., Schrope, B., Olivero-Rivera, L., Restuccia, N., Yuen, S., Fisk, M., Inabnet, W., Bessler, M., “Re-emergence of diabetes after gastric bypass in patients with mid- to long-term follow-up,” Surgery for Obesity and Related Diseases. 2010 May-Jun;6(3):249-53.
  • Milone L, Daud A, Durak E, Olivero-Rivera L, Schrope B, Inabnet WB, Davis D Bessler M. “Esophageal dilation after laparoscopic adjustable gastric banding,” Surgical Endoscopy, 2008, vol. 22, no. 6, pp. 1482-1486.
  • Gumbs A, Bessler M, Milone L, Schrope B, Chabot J. “Contribution of obesity to pancreatic carcinogenesis,” Surgery for Obesity and Related Diseases, March/April 2008, 4(2), pp. 186-93.
  • DiGiorgi M, Daud A, Inabnet W, Schrope B, Urban-Skuro M, Restuccia N, Bessler M. “Markers of Bone and Calcium Metabolism Following Gastric Bypass and Laparoscopic Adjustable Gastric Banding”, Obesity Surgery, Sep;18(9):1144-8.
  • Allendorf JD, Schrope BA, Lauerman MH, Inabnet WB, Chabot JA, “Postoperative Glycemic Control after Central Pancreatectomy for Mid-gland Lesions,” World Journal of Surgery, 2007, 31(1), pp. 164-168.
  • Bessler M, Daud A, DiGiorgi M, Inabnet W, Schrope B, Olivero-Rivera L, Davis D. “Adjustable gastric banding as revisional bariatric procedure after failed gastric bypass – intermediate results,” Surgery for Obesity and Related Diseases, Volume 6, Number 1, January/February 2010, pp 31-5.
  • Choi J, Digiorgi M, Milone L, Schrope B, Olivera-Rivera L, Daud A, Davis D, Bessler M. “Outcomes of laparoscopic adjustable gastric banding in patients with low body mass index,” Surgery for Obesity and Related Diseases, In Press, Uncorrected Proof, Available online 11 December 2009.
  • DiGiorgi M, Rosen D, Choi J, Milone L, Schrope B, Olivero-Rivera L, Restuccia N, Yuen S, Fisk, M, Inabnet W, Bessler M. “Re-emergence of diabetes after gastric bypass in patients with mid- to long-term follow-up,” Surgery for Obesity and Related Diseases, In Press, Uncorrected Proof, Available online 29 October 2009.
  • Korner J, Inabnet W, Febres G, Conwell IM, McMahon, DJ, Salas R, Taveras C, Schrope B, Bessler, M. “Prospective study of gut hormone and metabolic changes after adjustable gastric banding and Roux-en-Y gastric bypass,” International Journal of Obesity, vol. 33, 2009, pp. 786–795
  • Bessler M, Daud A, DiGiorgi M, Schrope B, Inabnet W, Davis D. “Frequency distribution of weight loss percentage after gastric bypass and adjustable gastric banding,” Surgery for Obesity and Related Diseases, Volume 4, Number 4, July-August 2008, pp 486-91.
  • Durak E, Inabnet W, Schrope B, Davis D, Daud A, Milone L., Bessler M. “Incidence and management of enteric leaks after gastric bypass for morbid obesity during a 10-year period,” Surgery for Obesity and Related Diseases, Volume 4, Number 3, May-June 2008, pp. 389-93.
  • Allendorf JD, Lauerman M, Bill A, DiGiorgi M, Goetz N, Vakiani E, Remotti H, Schrope B, Sherman W, Hall M. “Neoadjuvant Chemotherapy and Radiation for Patients with Locally Unresectable Pancreatic Adenocarcinoma: Feasibility, Efficacy, and Survival,” Journal of Gastrointestinal Surgery, 2008, 12(1), pp. 91-100.
  • Schrope B, Daud A, Bessler M. “Unintentional creation of a reverse peristaltic alimentary limb during Roux-en-Y gastric bypass surgery,” Surgery for Obesity and Related Diseases. July/August 2006; 2(4):478-82.
  • Kim T, Daud A, Ude A, DiGiorgi M, Schrope B, Davis D, Bessler M, Inabnet W. “Early U.S. outcomes comparing laparoscopic gastric bypass with laparoscopic adjustable gastric banding,” Surgical Endoscopy. February 2006; 20(2):202-9.
  • Dinorcia J, Schrope B. “Pancreaticoduodenectomy for Metastatic Ocular Melanoma: A Case Report.” Surgical Rounds. May 2006; pp 235-239.
  • Fogelman DR, Chen J, Chabot J, Allendorf J, Schrope B, Ennis R, Schreibman S, Fine F. “The evolution of adjuvant and neoadjuvant chemotherapy and radiation for advanced pancreatic cancer: from 5-FU to GTX.” Oncology Clinics of North America. 2004.
  • Stoutenberg JP, Schrope B, Kaufman HL. "Adjuvant therapy for malignant melanoma.” Expert Reviews in Anticancer Therapy. 2004; 4(5):89-101.

Conference Publications

  • Maria Moris Felgueroso, Maia Kayal, Elizabeth Hecht, Lyndon Luk, Amrita Sethi, John M. Poneros, Frank G. Gress, Beth Schrope, John A. Chabot, Marco J. Bruno, Djuna Cahen, Michael B. Wallace, Tamas A. Gonda, “Su1363: Multicenter Results of Long Term Surveillance of Intraductal Papillary Mucinous Neoplasms Without Worrisome Features,” presented at DDW 2016, San Diego, CA, May 21-25.
  • Ming-ming Xu, Shi Yin, Beth Schrope, Amrita Sethi, John M. Poneros, Frank G. Gress, Jeanine Genkinger, Catherine Do, John A. Chabot, Michael D. Kluger, Ali A. Siddiqui, Tamas A. Gonda, “Su1348:  Comparison of the Diagnostic Yield of Current Guidelines for the Evaluation of Asymptomatic Pancreatic Cystic Neoplasms,” presented at DDW 2016, San Diego, CA, May 21-25.
  • Kluger MD, Schrope BA, Hecht EM, Gulam MA, Saenger Y, Oberstein PE, Chabot JA,  “High rate of R0 resection following neoadjuvant chemoradiation for locally advanced pancreatic cancer: an incidental finding from irreversible electroporation-assisted resection,”  Presented at 50th Annual Pancreas Club Meeting, San Diego, CA; May 20-21, 2016.
  • Angela Lisa Carrelli, Mariana Bucovsky, Ronald L Hors, Serge Cremers, Chengchen Zhang, Marc Bessler, Beth Schrope, John Evanko, Jody Blanco, Shonni J. Silverberg, and Emily M. Stei1, “Vitamin D Storage in Adipose Tissue of Obese and Normal Weight Women,” presented at ENDO 2016, April 1-4 2016, Boston, Massachusetts.
  • T. Yanagihara, A. Jani, P.E. Oberstein, J.A. Chabot, W.H. Sherman, B.A. Schrope, Y. Woo, E.M. Hecht, R. Arindam, A. Chu, K. Salah, D. Addeo, D.P. Horowitz, “Stereotactic Body Radiation Therapy for Pancreatic Adenocarcinoma,” presented at the American Society for Radiation Oncology 57th Annual Meeting, October 18-21, 2015, in: International J of Radiation Oncology, November 1, 2015, Volume 93, Issue 3, Supplement, Page E140.
  • Maia Kayal, Lyndon Luk, Frank G. Gress, Amrita Sethi, John M. Poneros, Lauren G. Khanna, Ashish R. Shah, Beth Schrope, Elizabeth Hecht, Tamas A. Gonda, “Su1469:  Long Term Surveillance of Low-Intermediate Risk Intraductal Papillary Mucinous Neoplasms: A Single Center Experience,” presented at Digestive Disease Week, Washington, DC, May 16-19, 2015.
  • John A Chabot, Michael D Kluger, John D Allendorf, Beth A Schrope, Yanghee Woo, Robert L Fine, William H Sherman,  “Neoadjuvant chemoradiation for T4 pancreatic adenocarcinoma: a gemcitabine, docetaxol and capecitabine protocol offers superior outcomes,” presented at the 49th Annual Meeting of the Pancreas Club, Washington, DC, May 15-16, 2015.
  • Mary DiGiorgi, Monica P. Sangal, Talia Abecassis, Nancy Restuccia, Eileen Harvey, Beth Schrope, Melissa Bagloo, Marc Bessler, “Food Addiction and Long Term Weight Loss Outcomes Following Bariatric Surgery,” presented at the American Society for Metabolic and Bariatric Surgery Annual Meeting, Atlanta, Ga, November 11-16, 2013.
  • Melissa B Bagloo; Mary F DiGiorgi; Beth A Schrope; Miguel Silva; Akuezunkpa O Ude Welcome; Aaron Roth; Talia Abecassis; Monica P Sangal; Marc Bessler; Jeffrey L Zitsman, “A-102-P One year outcomes of sleeve gastectomy in pediatric vs. adult patients,” presented at the American Society for Metabolic and Bariatric Surgery Annual Meeting, Atlanta, Ga, November 11-16, 2013.
  • Nicholas J Christian; Wendy C King; Susan Z Yanovski; Marc Bessler; Anita P Courcoulas; Luis Garcia; Saurabh Khandelwal; John R Pender; Sheila Pierson; Walter J Pories; Beth A Schrope; Bruce M Wolfe, “A-196-P Validity of self-reported weights following bariatric surgery in the LABS-2 cohort,” presented at the American Society for Metabolic and Bariatric Surgery Annual Meeting, Atlanta, Ga, November 11-16, 2013.
  • Melissa B Bagloo; Beth A Schrope; Akuezunkpa O Ude Welcome; Mary F DiGiorgi; Laura DeCesare; Suxiao Yang; Avi Harari; Marc Bessler, MD, “A-270-P Chronic debilitating gastrointestinal symptoms: Outcomes of gastric bypass reversal,” presented at the American Society for Metabolic and Bariatric Surgery Annual Meeting, Atlanta, Ga, November 11-16, 2013.
  • Mary F DiGiorgi; Melissa B Bagloo; Beth A Schrope; Nancy L Restuccia; Eileen Harvey; Marc Bessler, “A-285-P Factors associated with long term weight regain after bariatric surgery,” presented at the American Society for Metabolic and Bariatric Surgery Annual Meeting, Atlanta, Ga, November 11-16, 2013.
  • Robert Fine, Yoomi Lee, William H. Sherman, Anthony Paul Gulati, Paul Eliezer Oberstein, Kyung Chu, Dawn Tsushima, Kelley B Mowatt, Beth Schrope, James A Lee, John Allendorf, John A Chabot, Stephen M. Schreibman, “Prospective phase II trial of GTX in metastatic pancreatic cancer: Laboratory and clinical studies,” J Clin Oncol 30: 2013 (suppl 34; abstr 209).
  • Paul Eliezer Oberstein, Anthony Paul Gulati, Benjamin A Krantz, Rebecca Anne Moss, Stephen M. Schreibman, Dawn Tsushima, Kelley B Mowatt, John Allendorf, Beth Schrope, James A Lee, William H. Sherman, John A Chabot, Robert Fine, “The efficacy and safety of the capecitabine/temozolomide (CAPTEM) regimen in the treatment of well-differentiated neuroendocrine tumors with liver metastasis after failure of previous therapy: Columbia University Medical Center experience,” J Clin Oncol 30: 2013 (suppl 34; abstr 308).
  • Irene Epelboym, Susan Hsiao, James A. Lee, Beth Schrope, John A. Chabot, Helen Remotti, John D. Allendorf, “Predictors of Recurrence and Post Recurrence Survival in Patients With Resected Ampullary Adenocarcinoma,” Gastroenterology, Volume 144, Issue 5, Supplement 1, May 2013, Pages S-1085.
  • Melissa Bagloo, Beth Schrope, “Laparoscopic Sleeve Gastrectomy As a Revision From Laparoscopic Adjustable Gastric Band - One Year Results,” Gastroenterology, Volume 144, Issue 5, Supplement 1, May 2013, Pages S-1087.
  • Irmina Gawlas, Irene Epelboym, Megan Winner, Joseph DiNorcia, Yanghee Woo, James A. Lee, Beth Schrope, John A. Chabot, John D. Allendorf, “Short-Term but Not Long-Term Patency of Venous Reconstruction During Pancreatic Resection Predicts Survival,” Gastroenterology, Volume 144, Issue 5, Supplement 1, May 2013, Pages S-1049.
  • Irene Epelboym, Irmina Gawlas, James A. Lee, Beth Schrope, John A. Chabot, John D. Allendorf, “Limitations of NSQIP in Reporting Complications for Patients Undergoing Pancreactectomy: Underscoring the Need for a Pancreas-Specific Module,” Gastroenterology, Volume 144, Issue 5, Supplement 1, May 2013, Pages S-1054–S-1055.
  • William H. Sherman, Kyung Chu, John Allendorf, John A Chabot, Beth Schrope, Robert Fine, “Greater than 3-year follow-up of concomitant gemcitabine, capecitabine, and radiation therapy in locally advanced or incompletely resected pancreatic cancer,” J Clin Oncol 30, 2012 (suppl; abstr e14708).
  • Epelboym, I., Winner, M., DiNorcia, J., Lee, M., Lee, J., Schrope, B., Chabot, J., Allendorf, J., “Quality of Life in Patients After Total Pancreatectomy is Comparable to Quality of Life in Patients After a Partial Pancreatic Resection,” Gastroenterology, Volume 142, Issue 5, Supplement 1, May 2012, p S-1078.
  • DiNorcia, J., Winner, M., Lee, M., Epelboym, I., Lee, J., Schrope, B., Chabot, J., Allendorf, J., “Neoadjuvant Therapy and Vascular Resection During Pancreaticoduodenectomy: Shifting the Survival Curve for Patients With Locally Advanced Pancreatic Cancer,” Gastroenterology, Volume 142, Issue 5, Supplement 1, May 2012, p S-1046.
  • Winner, M., Epelboym, I., DiNorcia, J., Lee, M., Lee, J., Schrope, B., Chabot, J., Allendorf, J., “Predictors of Recurrence in Intraductal Papillary Mucinous Neoplasm: Experience With 208 Pancreatic Resections,” Gastroenterology, Volume 142, Issue 5, Supplement 1, May 2012, pp S-1043-S-1044.
  • Equia, V., Winner, M., Sethi, A., Poneros, J., Lightdale, C., Allendorf, J., Chabot, J., Schrope, B., Lee, J., Gonda, T., “Preoperative EUS-FNA Does Not Adversely Affect Outcomes in Resectable Pancreatic Cancer,”Gastrointestinal Endoscopy, Volume 75, Issue 4, Supplement, April 2012, p AB194.
  • Lee, M., DiNorcia, J., Winner, M., Lee, J., Schrope, B., Chabot, J., Allendorf, J., “Glycemic Control in Non-Diabetic Patients is Associated With Better Outcomes Following Pancreatectomy,” Gastroenterology, Volume 140, Issue 5, Supplement 1, May 2011, pp S-1054.
  • Winner, M., Lee, M., DiNorcia, J., Lee, J., Schrope, B., Chabot, J., Allendorf, J., “One Hundred Forty Six Resections for Intraductal Papillary Mucinous Neoplasm of the Pancreas,” Gastroenterology, Volume 140, Issue 5, Supplement 1, May 2011, pp S-1022.
  • Winner, M., Lee, M., DiNorcia, J., Lee, J., Schrope, B., Chabot, J., Allendorf, J., “The Utility of Positron Emission Tomography Scans in the Diagnosis and Management of Pancreatic Adenocarcinoma,” Gastroenterology, Volume 140, Issue 5, Supplement 1, May 2011, pp S-1021-S-1022.
  • DiGiorgi, M., Mull, L., Restuccia, N., Bagloo, M., Schrope, B., Bessler, M., “Factors associated with weight regain after gastric bypass,” Surgery for Obesity and Related Diseases, Volume 7, Issue 3, May-June 2011, p 393.
  • DiGiorgi, M., Mull, L., Restuccia, N., Bagloo, M., Schrope, B., Ude, A.,  Bessler, M., “Effects of socioeconomic status on outcomes of gastric bypass surgery in hispanic patients,” Surgery for Obesity and Related Diseases, Volume 7, Issue 3, May-June 2011, p 408.
  • Bagloo, M., Purohit, M., DiGiorgi, M., Ude, A., Schrope, B., Bessler, M., “Conversion to gastric bypass after failed lap band results in weight loss equal to primary gastric bypass,” presented at the American Society for Metabolic and Bariatric Surgery Annual Meeting, Las Vegas, NV, June 27 – 30, 2010, Surgery for Obesity and Related Diseases.
  • DiNorcia, J, Schrope, B., Lee, M, Reavey, P, Lee, J., Chabot, J., and Allendorf, J., “Laparoscopic distal pancreatectomy offers shorter hospital stays with fewer complications,” presented at the Society for Surgery of the Alimentary Tract Annual Meeting, New Orleans, LA, May 1 – 5, 2010.
  • DiNorcia, J, Lee, M, Lee, J., Schrope, B., Chabot, J., and Allendorf, J., “127 resections for pancreatic neuroendocrine tumor: evaluating the impact of minimally invasive and parenchymal-sparing techniques,” presented at the Society for Surgery of the Alimentary Tract Annual Meeting, New Orleans, LA, May 1 – 5, 2010.
  • Lee, M., DiNorcia, J., Reavey, P., Holden, M., Lee, J., Schrope, B., Chabot, J., Allendorf, J., “Pancreaticoduodenectomy Can Be Performed Safely in Patients Aged 80 Years and Older,”Gastroenterology, Volume 138, Issue 5, Supplement 1, May 2010, pp S-874-S-875.
  • Ahmed, L, DiNorcia, J, Lee, M, Reavey, P, Yakaitis, E., Lee, J., Schrope, B., Chabot, J., and Allendorf, J., “Better preservation of endocrine and exocrine function following central versus distal pancreatectomy for midgland lesions,” presented at the Annual Meeting of the American Association of Endocrine Surgeons, Pittsburgh, PA, April 18 – 20, 2010.
  • Hu C, Ge F, Walewski J, Zhou S, Bessler M, Dakin G, Pomp A, Schrope, Ude A, Inabnet W, Lobdell H, Berk P. “Accumulation of increased triglyceride in obese fat is multifactorial, resulting both from increased uptake of long chain fatty acids and decreased fatty acid metabolism,”Obesity 2009, the annual meeting of The Obesity Society, Washington DC, October 24 – 28, 2009.
  • Choi J, Digiorgi M, Milone L, Daud A, Olivero-Rivera L, Schrope, Davis D, Bessler M. “Outcomes of laparoscopic adjustable gastric banding in low BMI patients,” presented at the American Society for Metabolic and Bariatric Surgery Annual Meeting, Grapevine, TX, June 24 – 27, 2009, Surgery for Obesity and Related Diseases, Volume 5, Number 35, May-June 2009, page S5.
  • Digiorgi M, Choi J, Milone L, Schrope, Olivero-Rivera L, Restuccia N, Urban-Skuro M, Inabnet W, Bessler M. “Recurrence of diabetes after gastric bypass in patients with mid to long-term follow up,” presented at the American Society for Metabolic and Bariatric Surgery Annual Meeting, Grapevine, TX, June 24 – 27, 2009, Surgery for Obesity and Related Diseases, Volume 5, Number 35, May-June 2009, page S13.
  • Allendorf J, Dinorcia J, Digiorgi M, Schrope, Lee J, Chabot J. “Pancreatectomy with venous resection and reconstruction: A single institution 15-year experience,” presented at the Ninth American Hepatopancreatobiliary Congress, Miami Beach, Fl, March 14, 2009, HPB, volume 11, supplement number 1, April 2009.
  • Gosman G, King W, Courcoulos A, Flum D, Hunter J, Pender J, Schrope, Steffen K, Strain G, Simhan H. “Reproductive health characteristics of women undergoing bariatric surgery,” presented at the American Society for Metabolic and Bariatric Surgery Annual Meeting, National Harbor, MD, June 15 – 20, 2008, Surgery for Obesity and Related Diseases, Volume 4, Number 3, May-June 2008, page 303.
  • Bessler M, Daud A, Inabnet W, Schrope, Davis D. “Adjustable gastric banding as a revisional bariatric procedure after failed gastric bypass – intermediate results,” presented at the American Society for Metabolic and Bariatric Surgery Annual Meeting, National Harbor, MD, June 15 – 20, 2008, Surgery for Obesity and Related Diseases, Volume 4, Number 3, May-June 2008, page 311
  • Schrope B, Blok J. “Ultrasound guidance for the difficult Lap Band adjustment,” presented at the American Society for Bariatric Surgery Annual Meeting, San Diego, CA , June 13 – 16, 2007. Surgery for Obesity and Related Diseases. May-June 2007; 3(3): 320.
  • Bessler M, Schrope B, Inabnet W, Davis D, Daud A. “Frequency distribution of weight loss and percentage after gastric bypass and adjustable gastric banding,” presented at the American Society for Bariatric Surgery Annual Meeting, San Diego, CA, June 13 – 16, 2007. Surgery for Obesity and Related Diseases. May-June 2007; 3(3): 284.
  • Durak E, Inabnet W, Schrope B, Davis D, Daud A, Milone L, Lee W, Bessler M. “Incidence, presentation and treatment of enteric leaks following gastric bypass,” presented at the American Society for Bariatric Surgery Annual Meeting, San Diego, CA, June 13 – 16, 2007. Surgery for Obesity and Related Diseases. May-June 2007; 3(3): 286.
  • Schrope B, Allendorf J, Dinorcia J, Bill A, Digiorgi M, Chabot J. “A single institution retrospective review of laparoscopic and open distal pancreatectomies,” presented at the Seventh American Hepatopancreatobiliary Congress, Las Vegas, NV, April 21, 2007. HPB. April 2007; Vol. 9. Supplement number 1.
  • Allendorf J, Lauerman M, Bill A, Digiorgi M, Goetz N, Schrope B, Sherman W, Fine R, Chabot J. “Neoadjuvant chemotherapy and radiation for patients with locally unresectable pancreatic adenocarcinoma: safety, efficacy and survival,” presented at the Seventh American Hepatopancreatobiliary Congress, Las Vegas, NV, April 21, 2007. HPB. April 2007; Vol. 9. Supplement number 1.
  • Milone L, Daud A, Durak E, Olivero-Rivera L, Schrope B, Inabnet W, Bessler M. “Effect of esophageal dilatation on weight loss at 1 year after laparoscopic gastric banding,” Society of American Gastrointestinal and Endoscopic Surgeons Annual Meeting, Las Vegas, NV, April 21, 2007.
  • Allendorf J, Lauerman M, Laskowski I, DiGiorgi M, Schrope B. “Pancreatectomy with vascular resection and reconstruction: A single institution 12 year experience,” The New York Surgical Society Conjoint Scientific Session with the Philadelphia Academy of Surgery, New York Academy of Medicine, April 18, 2007.
  • Digiorgi M, Daud A, Inabnet W, Schrope B, Urban-Skuro M, Restuccia N, Bessler M. “Markers of bone and calcium metabolism and effectiveness of supplementation following gastric bypass and laparoscopic adjustable gastric banding,” Annual Meeting of the American Society of Bariatric Surgery, San Francisco, CA, June 26 – July 1, 2006. Surgery for Obesity and Related Diseases. May-June 2006; 2(3): 299-300.
  • Urban-Skuro M, Daud A, Digiorgi M, Restuccia N, Inabnet W, Schrope B, Bessler M. “Zinc and selenium deficiency after weight loss surgery,” Annual Meeting of the American Society of Bariatric Surgery, San Francisco, CA, June 26 – July 1, 2006. Surgery for Obesity and Related Diseases. May-June 2006; 2(3): 354.
  • Allendorf J, Schrope B, InabnetW, Chabot J. “Postoperative Glycemic Control in Patients Undergoing Central Pancreatectomy for Mid-Gland Lesions,” International Surgical Week ISW 2005, Durban, South Africa, August 21-25, 2005.
  • Restuccia N, Olivero-Rivera L, Daud A, DiGiorgi M, Urban-Skuro M, Blok J, Schrope B, Inabnet W, Bessler M. “Effect of meal frequency on weight loss after bariatric surgery,” Annual Meeting of the American Society of Bariatric Surgery, Orlando, FL, June 27-30, 2005, Surgery for Obesity and Related Diseases. May-June 2005; 1(3): 244.
  • Daud A, Inabnet W, DiGiorgi M, Olivero-Rivera L, Schrope B, Davis D, Bessler M. “Effect of Bariatric Surgery in Elderly Patients,” Annual Meeting of the American Society of Bariatric Surgery, Orlando, FL, June 27-30, 2005. Surgery for Obesity and Related Diseases. May-June 2005; 1(3): 256.
  • Laskowski I, Allendorf J, Schrope B, Gabay M, Goetz N, Chabot J. “Pancreatectomy with vascular resection and reconstruction: A single institution 10-year experience.” Journal of Gastrointestinal Surgery. April 1, 2005; 9(4): 606.
  • Gondi V, Allendorf J, Twaddell W, Schrope B, Rotterdam H, Chabot J. “Lymphoplasmacytic sclerosing pancreatitis: A case report and review of 240 cases,” Journal of Gastrointestinal Surgery. April 1, 2005; 9(4): 60.
Locations

Herbert Irving Pavilion

161 Fort Washington Avenue
Room 821
New York, NY 10032

Phone: (212) 305-9441

Fax: (212) 342-1318

Get Directions


Associate Professor of Surgery at CUMC

  • Surgeon, ACS Center of Excellence in Bariatric Surgery, Center for Metabolic and Weight Loss Surgery, Valley Hospital, Ridgewood, NJ.
  • Surgeon, ACS Center of Excellence in Bariatric Surgery, Columbia University Center for Metabolic and Weight Loss Surgery, New York, NY.
  • Selected for inclusion in the 2007 - 2013 editions of “Guide to America’s Top Surgeons,” published by the Consumers’ Research Council of America.
  • Teaching Award, Department of Surgery, Columbia University College of Physicians and Surgeons, 2002 and 2009.